Published in Pharmazie on November 01, 1982
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage) (2006) 1.63
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis (2011) 1.15
Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput (1999) 1.08
Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther (1998) 1.07
Cyclophosphamide and related anticancer drugs. J Chromatogr B Biomed Sci Appl (2001) 1.06
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J (2008) 1.05
Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats. Neuroscience (2008) 1.00
Secretion of E,E-farnesol and biofilm formation in eight different Candida species. Antimicrob Agents Chemother (2008) 0.99
Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett (2001) 0.91
CYP2C and IL-6 expression in breast cancer. Breast (2004) 0.88
Different effects of diazepam in Fischer rats and two stocks of Wistar rats in tests of anxiety. Pharmacol Biochem Behav (2001) 0.86
Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver. J Cancer Res Clin Oncol (1987) 0.86
High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport (2000) 0.86
Gender difference in ifosfamide metabolism by human liver microsomes. Eur J Drug Metab Pharmacokinet (2001) 0.85
[The pharmacokinetics of bendamustine (Cytostasane) in humans]. Pharmazie (1985) 0.85
Circadian rhythms of dopamine and cholecystokinin in nucleus accumbens and striatum of rats--influence on dopaminergic stimulation. Chronobiol Int (1995) 0.85
HPLC-methods for determination of lipoic acid and its reduced form in human plasma. Int J Clin Pharmacol Ther Toxicol (1992) 0.83
Time-dependent inhibition of glioblastoma cell proliferation by dexamethasone. J Neurooncol (2001) 0.82
[Pharmacokinetics of bendamustin (Cytostasan) in B6D2F1-mice]. Pharmazie (1991) 0.81
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes. Br J Cancer (2004) 0.80
P450-expression in brain tumors. Oncol Res (1999) 0.79
A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Semin Oncol (1992) 0.79
Na,K-ATPase in excitation-contraction coupling of vascular smooth muscle from cattle. Acta Biol Med Ger (1979) 0.78
High-performance liquid chromatography methods for determination of lipoic and dihydrolipoic acid in human plasma. Methods Enzymol (1997) 0.78
D2 dopamine receptor occupancy, risperidone plasma level and extrapyramidal motor symptoms in previously drug-free schizophrenic patients. Int J Clin Pharmacol Ther (2005) 0.78
[Bioavailability of cyclophosphamide following oral administration in high doses]. Onkologie (1984) 0.77
Cisplatin (CDDP)-induced radiation resistance is not associated with CDDP resistance in 86HG39 and A172 malignant glioma cells. Eur J Cancer (1999) 0.77
Haloperidol serum concentrations and D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. Int Clin Psychopharmacol (1997) 0.77
Correlative circadian rhythms of cholecystokinin and dopamine content in nucleus accumbens and striatum of rat brain. Behav Brain Res (1993) 0.77
Determination of nicotine and cotinine in human serum by means of LC/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 0.77
Lewis acid-base adducts of group 13 elements: synthesis, structure and reactivity toward benzaldehyde. Dalton Trans (2016) 0.76
Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze. Eur Neuropsychopharmacol (1999) 0.76
Comparison by microdialysis of striatal L-DOPA after its systemic administration in rats with probes implanted acutely or through a guide cannula. J Neurosci Methods (2000) 0.76
Evaluation of the pharmacokinetics of dalteparin in patients with renal insufficiency. Int J Clin Pharmacol Ther (2006) 0.76
[Synthesis of a potential metabolite of the carcinostatic bendamustin (Cytostasen)]. Pharmazie (1991) 0.76
Modulation of multidrug resistance in human leukemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules. Int J Clin Pharmacol Ther (2000) 0.76
Feeding and 8-OH-DPAT-related release of serotonin in the rat lateral hypothalamus. Pharmacol Biochem Behav (2000) 0.76
Binding of cholecystokinin-8 (CCK-8) peptide derivatives to CCKA and CCKB receptors. J Neurochem (1994) 0.76
Poisoning with tilidine and naloxone: toxicokinetic and clinical observations. Hum Exp Toxicol (1998) 0.75
An ouabain-insensitive Na-ATPase of the arterial vascular muscle cell and its relation to ouabain-sensitive Na,K-ATPase. Acta Biol Med Ger (1979) 0.75
In vitro tolerance to inhibition by ethanol of N-methyl-D-aspartate-induced depolarization in locus coeruleus neurons of behaviorally ethanol-tolerant rats. Neurochem Int (2001) 0.75
The influence of pallidal deep brain stimulation on striatal dopaminergic metabolism in the rat. Neurosci Lett (2000) 0.75
Survival after massive "ecstasy" (MDMA) ingestion. Intensive Care Med (1999) 0.75
[Hormones and cytostatic drugs in cancer chemotherapy]. Z Gesamte Inn Med (1978) 0.75
Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects. Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Fiber-optic extrinsic Fabry-Perot interferometer strain sensor with <50 pm displacement resolution using three-wavelength digital phase demodulation. Opt Express (2001) 0.75
[Determination of prazosin (Adversuten) using HPLC and fluorescence detection]. Pharmazie (1983) 0.75
[Drug interactions with oral anticoagulants and cardiac glycosides]. Z Arztl Fortbild (Jena) (1981) 0.75
[Methods and application of the organ culture technique in clinical and experimental cancer research (author's transl)]. Arch Geschwulstforsch (1973) 0.75
Effect of external sodium and calcium on calcium efflux in arteria carotis of cattle. Acta Biol Med Ger (1979) 0.75
[Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)]. Arch Geschwulstforsch (1970) 0.75
Sodium flux and lipid spectrum in the erythrocyte membrane in essential hypertension. Int J Clin Pharmacol Ther Toxicol (1982) 0.75
[Treatment of small cell bronchial carcinoma with reference to stage classification]. Zentralbl Chir (1988) 0.75
[Chemo- and immunotherapy of malignant neoplasms]. Z Arztl Fortbild (Jena) (1975) 0.75
[Germ-reducing and controlling measurements (gnotobiotics) in patients with neoplasms endangered by infections and treated with cytostatic drugs]. Dtsch Gesundheitsw (1972) 0.75
Demonstration of a Mg-ATPase and a Na,K-ATPase from the arteria carotis communis of the sheep. Acta Biol Med Ger (1975) 0.75
CCK-8S facilitates 5-HT release in the rat hypothalamus. Pharmacol Biochem Behav (1998) 0.75
Extracellular amino acid levels in the striatum of the dt(sz) mutant, a model of paroxysmal dystonia. Neuroscience (2008) 0.75
[The paraneoplastic syndrome]. Z Gesamte Inn Med (1976) 0.75
[Cytostatic chemotherapy and sensitivity tests (oncobiograms) (author's transl)]. Z Erkr Atmungsorgane (1975) 0.75
[The value of supportive therapy in the treatment of malignant tumors]. Z Gesamte Inn Med (1978) 0.75
[New cytostatics and their clinical application (author's transl)]. Arch Geschwulstforsch (1978) 0.75
[Clinical evaluation of Bleomycin in tumor pateints]. Arch Geschwulstforsch (1973) 0.75
Time course and role of extracellular Ca2+ in veratridine-induced glutamate release. Neuroreport (1996) 0.75
The prismatic world of operating room nursing. NATNEWS (1970) 0.75
[Present state and improvement possibilities of self instruction in the education of medical students]. Z Arztl Fortbild (Jena) (1977) 0.75
[Clinical aspects of the excretion of alkylating cyclophosphamide metabolites in the urine of tumor bearing patients]. Onkologie (1978) 0.75
[Cytostatic treatment of non-seminoma testicular carcinomas]. Z Arztl Fortbild (Jena) (1983) 0.75
[Economics of prevention and therapy as shown on the example of phenylketonuria]. Z Arztl Fortbild (Jena) (1972) 0.75
[responses of blood pressure, respiration, and renal excretion of sodium, potassium and chloride following stimulation of arterial chemoreceptors with cyanide solutions in various concentrations]. Acta Biol Med Ger (1971) 0.75
Investigations on the dose-dependent pharmacokinetics of adriamycin and its metabolites. Int J Clin Pharmacol Ther Toxicol (1989) 0.75
[Value of CEA determination in follow-up of patients with liver metastasis of colorectal cancers with loco-regional chemotherapy]. Zentralbl Chir (1991) 0.75
3-O-methyl-DOPA is not involved in the development of behavioral supersensitivity after repeated L-dopa administration in 6-OHDA lesioned rats. Behav Brain Res (1994) 0.75
[Synthesis and biological activity of new cholecystokinin (CCK)-analogs with a special CCK-A receptor antagonistic effect]. Pharmazie (1990) 0.75
A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Semin Oncol (1992) 0.75
[Properties and toxicology of polytetrafluoroethylene and its use in industry and medicine]. Pharmazie (1973) 0.75
The operating department team. Nurs Times (1973) 0.75
[Complementary radiotherapy and chemotherapy in the surgical treatment of broncho-pulmonary cancer]. Bronches (1974) 0.75
[Cardiotoxic side effects of adriamycin]. Z Arztl Fortbild (Jena) (1983) 0.75
[Significance of the cell cycle for the effect of antineoplastic chemotherapy]. Acta Histochem Suppl (1983) 0.75
[Absorption of high doses of cyclophosphamide given orally]. Pharmazie (1983) 0.75
[Methyl-GAG, an effective cytotoxic drug for treatment of neoplastic exsudates (author's transl)]. Arch Geschwulstforsch (1974) 0.75
Excretion patterns of alkylating metabolites in urine following cyclophosphamide treatment of tumor patients: influence of application route, dosage, liver and kidney function. J Cancer Res Clin Oncol (1979) 0.75
Characterization of Mg-ATPase and (Na+ + K+)-stimulated Mg-ATPase in smooth muscular cells of the sheep's common carotid artery. Acta Biol Med Ger (1976) 0.75
Effect of tertiary amine on the carbodiimide-mediated peptide synthesis. Int J Pept Protein Res (1991) 0.75